Kiniksa Pharmaceuticals

$16.11
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.58 (-8.93%) As of 7:57 PM UTC today

Why Robinhood?

You can buy or sell KNSA and other stocks, options, and ETFs commission-free!

About KNSA

Kiniksa Pharmaceuticals, Ltd. Class A Common Stock, also called Kiniksa Pharmaceuticals, is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.

CEO
Sanj K. Patel
Employees
168
Headquarters
Hamilton, Hamilton
Founded
2015
Market Cap
1.08B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
605.90K
High Today
$17.71
Low Today
$15.91
Open Price
$17.70
Volume
678.65K
52 Week High
$28.67
52 Week Low
$14.51

KNSA Earnings

-$0.79
-$0.53
-$0.26
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Apr 28, Pre-Market

You May Also Like

RDVT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure